Literature DB >> 20005803

Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K.

Seogang Hyun1, Jung Hyun Lee, Hua Jin, JinWu Nam, Bumjin Namkoong, Gina Lee, Jongkyeong Chung, V Narry Kim.   

Abstract

How body size is determined is a long-standing question in biology, yet its regulatory mechanisms remain largely unknown. Here, we find that a conserved microRNA miR-8 and its target, USH, regulate body size in Drosophila. miR-8 null flies are smaller in size and defective in insulin signaling in fat body that is the fly counterpart of liver and adipose tissue. Fat body-specific expression and clonal analyses reveal that miR-8 activates PI3K, thereby promoting fat cell growth cell-autonomously and enhancing organismal growth non-cell-autonomously. Comparative analyses identify USH and its human homolog, FOG2, as the targets of fly miR-8 and human miR-200, respectively. USH/FOG2 inhibits PI3K activity, suppressing cell growth in both flies and humans. FOG2 directly binds to p85alpha, the regulatory subunit of PI3K, and interferes with the formation of a PI3K complex. Our study identifies two novel regulators of insulin signaling, miR-8/miR-200 and USH/FOG2, and suggests their roles in adolescent growth, aging, and cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005803     DOI: 10.1016/j.cell.2009.11.020

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  128 in total

Review 1.  From microRNAs to targets: pathway discovery in cell fate transitions.

Authors:  Deepa Subramanyam; Robert Blelloch
Journal:  Curr Opin Genet Dev       Date:  2011-06-01       Impact factor: 5.578

2.  MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.

Authors:  Keun Hur; Yuji Toiyama; Masanobu Takahashi; Francesc Balaguer; Takeshi Nagasaka; Junichi Koike; Hiromichi Hemmi; Minoru Koi; C Richard Boland; Ajay Goel
Journal:  Gut       Date:  2012-06-26       Impact factor: 23.059

3.  Conserved microRNA miR-8 controls body size in response to steroid signaling in Drosophila.

Authors:  Hua Jin; V Narry Kim; Seogang Hyun
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

4.  MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells.

Authors:  Wei Xia; Jie Li; Liucun Chen; Baochun Huang; Shaohua Li; Guang Yang; Hongmei Ding; Fang Wang; Nongle Liu; Qiang Zhao; Tao Fang; Tao Song; Tianyou Wang; Ningsheng Shao
Journal:  Mol Cell Biochem       Date:  2010-08-04       Impact factor: 3.396

Review 5.  The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?

Authors:  Simone Brabletz; Thomas Brabletz
Journal:  EMBO Rep       Date:  2010-08-13       Impact factor: 8.807

Review 6.  The Systemic Control of Growth.

Authors:  Laura Boulan; Marco Milán; Pierre Léopold
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-10       Impact factor: 10.005

7.  MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.

Authors:  Lixia Guo; Jingyu Wang; Ping Yang; Qiang Lu; Ting Zhang; Yanan Yang
Journal:  IUBMB Life       Date:  2015-08-27       Impact factor: 3.885

8.  TALEN-based knockout library for human microRNAs.

Authors:  Young-Kook Kim; Gabbine Wee; Joha Park; Jongkyu Kim; Daehyun Baek; Jin-Soo Kim; V Narry Kim
Journal:  Nat Struct Mol Biol       Date:  2013-11-10       Impact factor: 15.369

9.  miR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings.

Authors:  Kelsey Bolin; Nicholas Rachmaninoff; Kea Moncada; Katharine Pula; Jennifer Kennell; Laura Buttitta
Journal:  Dev Biol       Date:  2016-02-21       Impact factor: 3.582

10.  miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops.

Authors:  Libing Song; Chuyong Lin; Hui Gong; Chanjuan Wang; Liping Liu; Jueheng Wu; Sha Tao; Bo Hu; Shi-Yuan Cheng; Mengfeng Li; Jun Li
Journal:  Cell Res       Date:  2012-12-18       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.